Anderson Edward T

Director, 10% OwnerLyra Therapeutics, Inc. (LYRA) · full profile →Form 4 · filed Jun 2, 2023
Net Buying
Open-Market Buys
$4.4M
Open-Market Sells
$0
Net Open-Market Flow
$4.4M
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 31, 2023Buy(P)404K$2.43$981K2.3M
May 31, 2023Buy(P)1.2M$2.43$2.9M2.5M
May 31, 2023Buy(P)198K$2.43$481K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 31, 2023Buy(P)99K$0.13$13K99K
May 31, 2023Buy(P)202K$0.13$26K202K
May 31, 2023Buy(P)602K$0.13$78K602K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-014350) within minutes of acceptance. Every field above traces to the original document. Verify it directly: